S

SSY Group Ltd
HKEX:2005

Watchlist Manager
SSY Group Ltd
HKEX:2005
Watchlist
Price: 3.73 HKD -2.1% Market Closed
Market Cap: 11B HKD
Have any thoughts about
SSY Group Ltd?
Write Note

SSY Group Ltd
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SSY Group Ltd
Income to Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
S
SSY Group Ltd
HKEX:2005
Income to Minority Interest
-HK$11.8m
CAGR 3-Years
-178%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Income to Minority Interest
-HK$17.8m
CAGR 3-Years
-82%
CAGR 5-Years
-13%
CAGR 10-Years
-18%
U
United Laboratories International Holdings Ltd
HKEX:3933
Income to Minority Interest
ÂĄ658k
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sino Biopharmaceutical Ltd
HKEX:1177
Income to Minority Interest
-ÂĄ2.9B
CAGR 3-Years
-15%
CAGR 5-Years
-10%
CAGR 10-Years
-16%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Income to Minority Interest
-HK$6.9B
CAGR 3-Years
-38%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Income to Minority Interest
$239k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SSY Group Ltd
Glance View

Market Cap
11.1B HKD
Industry
Pharmaceuticals

SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company employs 4,800 full-time employees The company went IPO on 2005-12-20. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.

Intrinsic Value
5.41 HKD
Undervaluation 31%
Intrinsic Value
Price
S

See Also

What is SSY Group Ltd's Income to Minority Interest?
Income to Minority Interest
-11.8m HKD

Based on the financial report for Jun 30, 2024, SSY Group Ltd's Income to Minority Interest amounts to -11.8m HKD.

What is SSY Group Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 5Y
-24%

Over the last year, the Income to Minority Interest growth was 67%. The average annual Income to Minority Interest growth rates for SSY Group Ltd have been -178% over the past three years , -24% over the past five years .

Back to Top